Zhang Wenjuan, Yu Tao, Wang Yunshuang, Hu Meili, Gao Tianxiang
Wenjuan Zhang, Department of Clinical Laboratory, Baoding Maternal and Child Health Hospital, Baoding 071000, Hebei, China.
Tao Yu, Department of Clinical Laboratory, Baoding Maternal and Child Health Hospital, Baoding 071000, Hebei, China.
Pak J Med Sci. 2024 Mar-Apr;40(4):741-746. doi: 10.12669/pjms.40.4.7530.
To investigate the value of the combined test of seven blood coagulation indexes, lipids and platelet agglutination on the evaluation of the hypercoagulable state of blood in parturient women.
This is a retrospective study. Total 50 high risk parturient women who underwent an antenatal examination in Baoding Maternal and Child Health Hospital from June 2021 to January 2023 were selected as the observation group, while 50 normal parturient women who underwent antenatal examination without comorbidities and complications were randomly collected in a ratio of 1:1 as the control group. All subjects had venous blood drawn for testing of seven blood coagulation indexes, lipids and platelet agglutination before delivery, and their general data were recorded.
The activated partial thromboplastin time(APTT) in the observation group was lower than that in the control group, while thrombin time(TT) and D-dimer(DD) were both higher than those in the control group, with statistically significant differences(p<0.05); total cholesterol (TC) and triglyceride (TG) in the observation group were both higher than those in the control group, with statistically significant differences (p<0.05); adenosine diphosphate (ADP) and arachidonic acid (AA) in the observation group were both higher than those in the control group, with statistically significant differences (p<0.05). Moreover, the overall incidence of adverse pregnancy was higher in the observation group than in the control group, with a statistically significant difference (p<0.05).
The combined test of seven blood coagulation indexes, lipids and platelet agglutination results in excellent performance in predicting and judging the presence or absence of the hypercoagulable state of blood in parturient women, with the combination of APTT+TT+DD+TG+ADP+AA being the preferred test.
探讨凝血七项指标、血脂及血小板凝集联合检测在评估孕产妇血液高凝状态中的价值。
本研究为回顾性研究。选取2021年6月至2023年1月在保定市妇幼保健院进行产前检查的50例高危孕产妇作为观察组,同时按1:1比例随机收集50例无合并症及并发症的正常孕产妇作为对照组。所有研究对象在分娩前均抽取静脉血检测凝血七项指标、血脂及血小板凝集,并记录其一般资料。
观察组活化部分凝血活酶时间(APTT)低于对照组,凝血酶时间(TT)和D-二聚体(DD)均高于对照组,差异有统计学意义(p<0.05);观察组总胆固醇(TC)和甘油三酯(TG)均高于对照组,差异有统计学意义(p<0.05);观察组二磷酸腺苷(ADP)和花生四烯酸(AA)均高于对照组,差异有统计学意义(p<0.05)。此外,观察组不良妊娠总发生率高于对照组,差异有统计学意义(p<0.05)。
凝血七项指标、血脂及血小板凝集联合检测对预测和判断孕产妇血液高凝状态具有良好性能,其中APTT+TT+DD+TG+ADP+AA联合检测为首选。